ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

FTLF vs JNJ // GROSS PROFIT MARGIN

FitLife Brands Inc. (NASDAQ) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: FTLF 3 — JNJ 8
▲ GROSS PROFIT MARGIN LEADER: JNJ
gross-margins
67.90%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (FTLF VS. JNJ) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC FTLF JNJ SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin ACTIVE 43.10% 67.90% -24.80 JNJ /gross-margins <GO>
Return on Invested Capital (ROIC) 5.40% 25.50% -20.10 JNJ /roic <GO>
EV/EBITDA & P/E Valuation 24.8x 18.5x +6.30 JNJ /valuation <GO>
Free Cash Flow Yield 9.96% 2.97% +6.99 FTLF /fcf-yield <GO>
Operating Margin 18.60% 34.70% -16.10 JNJ /operating-margins <GO>
Net Profit Margin 39.70% 28.50% +11.20 FTLF /net-margins <GO>
Revenue Growth (YoY) — 6.00% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 1.24 5.59 -4.35 JNJ /balance-sheet <GO>
Piotroski F-Score Quality 6/9 8/9 -2.00 JNJ /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 31.7 62.1 -30.40 JNJ /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — 1.08 — TIE /macro-sensitivity <GO>
Forward P/E Multiple 10.9x 23.0x -12.10 FTLF /forward-pe <GO>
Enterprise Scale & Market Cap $74.3M $662.49B -$662.42B JNJ /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR FTLF REV JNJ REV FTLF GROSS % JNJ GROSS % FTLF FCF JNJ FCF
FY 2025 $15.9M $94.19B 43.1% 67.9% $7.4M $19.70B
FY 2024 $64.5M $88.82B 43.6% 69.1% $9.6M $19.84B
FY 2023 $0 $85.16B — — $4.2M $18.96B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
FTLF // BETA —
JNJ // BETA 1.08